Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by 1357councilrockon May 31, 2024 11:19am
268 Views
Post# 36066317

Is it time?

Is it time?Seems to me thatRuvidar/PDT is demonstrating such promise that somewhere in the medical realm a realization wshould develop that this treatment protocol must be elevated tin the fastest possible way to approval.

TLT pounding the table will not get the attention required and RDW, because of past regulatory issues, may not be being as aggressive as the situation warrants.

I believe that we need a home run hitter in the batters box for this to happen. RDW, whose keen visionary skills got us to this point , may not have the additional skill set to pull this off.

There are high-powered, high stature firms who know how to make these things happen. 

It's time to move into this mode, IMO. Just now TLT seems to be stuck, spinning wheels. The market agrees, it is saying "Do something!".







<< Previous
Bullboard Posts
Next >>